Dec 17 (Reuters) - Healius Ltd (HLS) :
- TO ACQUIRE 100% OF AGILEX BIOLABS PTY LTD FOR AN ENTERPRISE VALUE OF A$301.3 MILLION
- ACQUISITION IS EXPECTED TO DELIVER LOW SINGLE DIGIT EPS ACCRETION IN FIRST FULL YEAR OF OWNERSHIP
- ESTIMATED CY22 REVENUE AND EBITDA IS WITHIN A RANGE OF A$36-40 MILLION AND A$14-16 MILLION, RESPECTIVELY
News: HLS Healius Says To Buy Agilex Biolabs For Enterprise Value Of A$301.3 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
-0.015(1.85%) |
Mkt cap ! $577.2M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 80.8¢ | 78.5¢ | $1.868M | 2.348M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11177 | 78.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 29995 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2025 (20 minute delay) ? |
| HLS (ASX) Chart |